Veritable’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-2,073
| Closed | -$256K | – | 743 |
|
|
2020
Q2 | $256K | Buy |
+2,073
| New | +$256K | 0.01% | 633 |
|
|
2020
Q1 | – | Sell |
-2,540
| Closed | -$215K | – | 736 |
|
|
2019
Q4 | $215K | Buy |
+2,540
| New | +$215K | ﹤0.01% | 768 |
|
|
2019
Q2 | – | Sell |
-2,493
| Closed | -$221K | – | 800 |
|
|
2019
Q1 | $221K | Buy |
+2,493
| New | +$221K | ﹤0.01% | 727 |
|
|
2018
Q4 | – | Sell |
-2,205
| Closed | -$214K | – | 774 |
|
|
2018
Q3 | $214K | Buy |
2,205
+29
| +1% | +$2.82K | ﹤0.01% | 758 |
|
|
2018
Q2 | $205K | Buy |
+2,176
| New | +$205K | ﹤0.01% | 750 |
|
|
2018
Q1 | – | Sell |
-3,555
| Closed | -$317K | – | 795 |
|
|
2017
Q4 | $317K | Buy |
+3,555
| New | +$317K | 0.01% | 610 |
|
|
2016
Q4 | – | Sell |
-2,267
| Closed | -$210K | – | 736 |
|
|
2016
Q3 | $210K | Buy |
+2,267
| New | +$210K | 0.01% | 674 |
|
|
2016
Q1 | – | Sell |
-1,964
| Closed | -$206K | – | 705 |
|
|
2015
Q4 | $206K | Buy |
+1,964
| New | +$206K | 0.01% | 678 |
|
|
2015
Q3 | – | Sell |
-1,618
| Closed | -$221K | – | 713 |
|
|
2015
Q2 | $221K | Sell |
1,618
-10,601
| -87% | -$1.45M | 0.01% | 660 |
|
|
2015
Q1 | $1.52M | Buy |
12,219
+510
| +4% | +$63.6K | 0.03% | 308 |
|
|
2014
Q4 | $1.06M | Buy |
11,709
+1,220
| +12% | +$110K | 0.02% | 395 |
|
|
2014
Q3 | $757K | Buy |
10,489
+424
| +4% | +$30.6K | 0.02% | 481 |
|
|
2014
Q2 | $626K | Buy |
10,065
+2,120
| +27% | +$132K | 0.01% | 532 |
|
|
2014
Q1 | $542K | Hold |
7,945
| – | – | 0.01% | 563 |
|
|
2013
Q4 | $559K | Hold |
7,945
| – | – | 0.01% | 545 |
|
|
2013
Q3 | $573K | Sell |
7,945
-3,190
| -29% | -$230K | 0.01% | 525 |
|
|
2013
Q2 | $621K | Buy |
+11,135
| New | +$621K | 0.01% | 506 |
|